Pharmaceutical Preparations · DE · CIK 1347178
Develops and commercializes innovative therapies for unmet medical needs using genetics and genomics
Comparable business profile · signals at a glance
In the 90 days to Mar 2, 2026: 6 sold $2.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Polymeropoulos Mihael HristosPresident and CEO | Sell | 156,235 | $8.17 | $1.3M |
| Mar 2, 2026 | Moran Kevin PatrickSVP, CFO & Treasurer | Sell | 42,442 | $8.27 | $351K |
| Mar 2, 2026 | Williams TimothySVP & General Counsel | Sell | 42,434 | $8.27 | $351K |
| Mar 2, 2026 | Birznieks GuntherSVP, Business Development | Sell | 42,431 | $8.27 | $351K |
| Mar 2, 2026 | Wijkstrom JoakimSVP, Chief Marketing Officer | Sell | 30,800 | $8.27 | $255K |
| Feb 23, 2026 | Honore TageDirector | Sell | 30,000 | $8.03 | $241K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.